HPS1526-95
111543-77-2
默认>95%HPLC，若需其他规格请洽询
| 产品编号 | 规格 | 货期 | 销售价 | 折扣价 | 数量 | 操作 |
|---|---|---|---|---|---|---|
| HPS1526-95 | 默认>95%HPLC，若需其他规格请洽询 |
25天
|
敬请询价 | 敬请询价 |
 
|
| 名字 | H-Asp-Ala-His-Lys-OH |
|---|---|
| 序列(三字母) | H-Asp-Ala-His-Lys-OH |
| 序列(单字母) | DAHK |
| CAS# | 111543-77-2 |
| 分子式 | C₁₉H₃₁N₇O₇ |
| 分子量 | 469.5 |
| 纯度 | 默认>95%HPLC，若需其他规格请洽询 |
| 合成方法 | Synthetic |
| 储存条件 | -20 ± 5 °C |
| 应用 | Apoptosis & Necrosis|Cardiovascular System & Diseases |
| 描述 | The tetrapeptide DAHK corresponding to the N-terminal sequence of human serum albumin forms a tight binding site for Cu(II) ions. DAHK inhibits Cu(II)-induced oxidative DNA double strand breaks. The tetrapeptide is as effective as HSA in preventing neuronal death induced by CuCl₂/ascorbic acid. DAHK may be an effective, small-molecular-weight alternative to HSA as a therapeutic agent for stroke. |
